2.0
25. Juli 2023
Mitarbeiter (anonym)
Aktueller Mitarbeiter, mehr als 8 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
There are still people here who care and want the company to succeed. The benefits are still good (for now), and the managers who haven't been laid off yet still make an effor to see their employees succeed.
Kontras
Biogen used to be focused on helping patients, but ever since Chris Viehbacher took over the focus is all on money. We've started a "Fit for Growth" program that seems focused on making investors happy at the expense of patients and employees, and looking at our stock price right now we can't even do that. Communication is mostly ominous these days and gives me almost no faith that this place is going to be somewhere that people want to work moving forward, assuming the manufacturing plant isn't spun off or sold entirely.